Shimla Online

(Albany, US) DelveInsight has launched a new report on “Diabetic foot ulcers Market Insights, Epidemiology, and Market Forecast-2030“. 

DelveInsight’s “Diabetic foot ulcers Market Insights, Epidemiology, and Market Forecast -2030“ report delivers an in-depth understanding of the Diabetic foot ulcers, historical and forecasted epidemiology as well as the Diabetic foot ulcers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some of the Facts:

• The global diabetic foot ulcer prevalence was 6.3%, which was higher in males than in females.
• North America had the highest Diabetic Foot Ulcers prevalence, Oceania had the lowest and Diabetic Foot Ulcers prevalence in Europe, and Africa were 5.1% and 7.2%, respectively.
• 10-30% of diabetic patients with a foot ulcer will eventually progress to amputation. The prevalence of foot ulcers among diabetic patients ranges from 2% to 12%.
• Approximately 451 million adults worldwide have diabetes, a figure projected to increase to 693 million by 2045 globally.

 

Request for free sample report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market

 

Scope of the Report

• The report covers the descriptive overview of Diabetic foot ulcers, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Diabetic foot ulcers epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Diabetic foot ulcers are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Diabetic foot ulcers market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Diabetic foot ulcers market

“Over 55 million Europeans suffer from diabetes, and 8 million of these patients are at risk of developing a diabetic foot ulcer.”

 

Diabetic foot ulcersis a lesion of all layers of skin, necrosis, or gangrene that occurs in the sole of the feet in diabetes mellitus (DM) patients, caused by: (1) causative factor (peripheral neuropathy, high foot plantar pressure, and trauma); (2) contributive factors (atherosclerosis and diabetes). Diabetic foot ulcers can be followed by bacterial invasion resulting in infection and decay, can occur in any part of the body especially in the distal part of the lower leg. The sign and symptoms of Diabetic foot ulcers (DFU) includes, swelling, discoloration, and warmth around the wound, foul-smelling discharge seeping from the wound, Pain and firmness when the wound is touched and Call used or thickened skin surrounding the ulcer.

Request for free sample report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market

According to Edmon, the diabetic foot ulcers are divided into two groups, namely: Neuropathic ulcers (feet is warm, perfusion is still good with pulsation still palpable, perspiration is reduced, skin dry and cracked).

Neuroischemic ulcers (feet is colder, not palpable pulsation, thin skin, smooth, and without hair, subcutaneous tissue atrophy, intermittent claudication, and rest pain may not be present due to neuropathy).

 

Some of the Diabetic foot ulcers Companies:

• Origin
• Microbion Corporation
• Smith & Nephew
• Venturis Therapeutics
• And many others

 

Diabetic foot ulcers Drugs Covered:

• Plasma-generated nitric oxide
• MBN-101
• Regranex Gel (becaplermin)
• CVBT-141
• And many others

 

Request for free sample report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market

 

Table of Contents:

1. Report Introduction

2. Diabetic Foot Ulcers Market Overview at a Glance

3. Diabetic Foot Ulcers Disease Background and Overview

4. Diabetic Foot Ulcers Epidemiology and Patient Population

5. Diabetic Foot Ulcers Country- Wise Epidemiology

5.1. United States

5.2. EU-5

5.2.1. Germany

5.2.2. France

5.2.3. Italy

5.2.4. Spain

5.2.5. United Kingdom

5.3. Japan

6. Diabetic Foot Ulcers Treatment & Medical Practices

7. Diabetic Foot Ulcers Marketed Drugs

7.1. Regranex Gel (becaplermin): Smith & Nephew

8. Diabetic Foot Ulcers Emerging Therapies

8.1. Key Cross Competition

8.2. Plasma-generated nitric oxide: Originww

8.3. MBN-101: Microbion Corporation

9. Diabetic Foot Ulcers Market Size

10. 7MM Diabetic Foot Ulcers Country-Wise Market Analysis

10.1. United States

10.2. Germany

10.3. France

10.4. Italy

10.5. Spain

10.6. United Kingdom

10.7. Japan

11. Diabetic Foot Ulcers Report Methodology

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

Related Reports:

• Diabetic Ketoacidosis (DKA) – Market Insight, Epidemiology and Market Forecast – 2030
• Diabetic retinopathy – Epidemiology Forecast to 2030
• Diabetic foot ulcers (DFUs) – Epidemiology Forecast to 2030
• Diabetic Gastroparesis – Epidemiology Forecast-2030
• Diabetic Macular Edema (DME) – Epidemiology Forecast to 2030

About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market